MedPath

Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study

Not Applicable
Terminated
Conditions
Respiration Rate
Interventions
Device: INVSENSOR00004
Registration Number
NCT03482505
Lead Sponsor
Masimo Corporation
Brief Summary

The objective of this clinical investigational study is to compare the acoustic respiration rates (RRa) obtained using the INVSENSOR0004 sensor in the subjects up to 10 kg with the respiration rates determined by manual annotations (RRref), and when applicable with capnography respiration rate (RRcap).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Subjects weighing up to 10kg
  • Subjects will be inpatients and/or outpatients admitted to the NICU (Neonatal Intensive Care Unit) or PICU (Pediatric Intensive Care Unit) or PACU (Post-Anaesthesia Care Unit)
  • The parent/legal guardian has given written informed consent/assent to participate in the study.
Exclusion Criteria
  • Subjects with underdeveloped skin
  • Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
  • Subjects deemed not suitable for the study at the discretion of the investigator.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
INVSENSOR00004INVSENSOR00004All enrolled subjects will receive the INVSENSOR00004 sensor. The INVSENSOR00004 rainbow acoustic monitoring (RAM) acoustic respiration sensor is designed to noninvasively convert acoustical airflow patterns into respiratory rate (RRa).
Primary Outcome Measures
NameTimeMethod
Accuracy of Acoustic Respiration Rate (RRa)One study visit lasting up to 60 minutes.

Acoustic respiration rate (RRa) as determined by the INVSENSOR00004 will be compared to measurements of actual respiration rates as determined by manual annotation of recorded respiration waveform (RRref) data. Evaluation of the RRa measurements will be reported as bias between the RRa and the RRref.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Loma Linda University Medical Center

🇺🇸

Loma Linda, California, United States

Children's Medical Center Dallas

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath